Tag: Immuno-oncology
Merck & Moderna’s Personalized mRNA Cancer Vaccine Succeeds in Phase 3 Melanoma Trial
Pharmaceutical giants Merck and Modernarevealed encouraging results from their Phase 3 INTerpath-001 study, testing an individualized mRNA cancer vaccine alongside Merck's immunotherapy drug Keytruda in melanoma patients.
The...
Immuneel Therapeutics and Tata Memorial Centre Partner to Advance Cell & Gene Therapy in India
Immuneel Therapeutics Pvt. Ltd. has announced a strategic collaboration with the Tata Memorial Centre (TMC) to advance Cell & Gene Therapy (CGT) research and development in India.
This...
